Walgreens Boots Alliance (WBA) unveiled a definitive agreement late Thursday to be acquired by an entity affiliated with Sycamore Partners for up to $23.7 billion.
The price tag is based on a cash consideration of $11.45 per share and up to $3 per divested-asset-proceed right, plus net debt, capital leases, present value of opioid liability, and a settlement, Walgreens said. Walgreens will become a private entity and its shares will crease to trade on Nasdaq upon deal close.
The cash consideration represents a 29% premium, and the total consideration represents a premium of up to 63% to Walgreens closing share price of $8.85 as of Dec. 9, the day before media reported the deal.
The transaction has been approved by Walgreens' board and is expected to close in Q4, subject to certain approvals and customary conditions.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。